Study design for technology assessment: critical issues

Area of Science:

• Health Services Research
• Epidemiology
• Health Policy Analysis

Background:

• Epidemiological methods are vital for evaluating healthcare technologies.
• Randomized controlled trials (RCTs) provide robust evidence but are not always feasible.
• Ethical considerations and intervention nature can limit RCT application.

Purpose of the Study:

• To discuss critical issues in quasi-experimental and non-experimental study designs for healthcare technology assessment.
• To highlight the importance of evaluative study results for health policy decision-making.
• To emphasize that impact measurement should extend beyond effectiveness to include health status and quality of life.

Main Methods:

• Review and discussion of epidemiological study designs.
• Analysis of challenges in applying randomized controlled trials (RCTs).
• Consideration of quasi-experimental and non-experimental approaches.

Main Results:

• Quasi-experimental and non-experimental designs are necessary alternatives when RCTs are not feasible.
• Critical issues related to these alternative designs require careful consideration.
• Evaluative study outcomes are essential for informing health policy.

Conclusions:

• The choice of epidemiological study design impacts the assessment of healthcare technologies.
• Comprehensive evaluation must include health status and quality of life, not just effectiveness.
• Informed decision-making in health policy relies on robust evaluative study results.